INVESTORS + MEDIA

Aerami Therapeutics is developing novel inhaled therapies for the treatment of chronic diseases. Our platform is designed to overcome limitations of injectable and other inhaled formulation technologies for managing chronic diseases, and ultimately improve treatment efficacy and patient experience.